Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Breast Neoplasms 48Neoplasm Metastasis 4Hereditary Sensory and Autonomic Neuropathies 4Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Hyperglycemia 3Multiple Endocrine Neoplasia Type 1 2Advanced Breast Cancer 2Sarcoma 1Recurrence 1Prostatic Neoplasms 1Pre-menopausal Breast Cancer 1Pancreatic Neoplasms 1Melanoma 1Kidney Neoplasms 1Hormone Receptor Positive Breast Carcinoma 1Head and Neck Neoplasms 1HER2-positive Metastatic Breast Cancer 1Genetic Diseases, Inborn 1Gastrointestinal Neoplasms 1Exanthema 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Ductal, Breast 1Anatomic Stage III Breast Cancer AJCC v8 1Advanced or Metastatic ER+ Breast Cancer 1Advanced Solid Tumors With an Alteration of the PIK3CA Gene 1Advanced HER2+Breast Cancer 1

Interventions

pembrolizumab 9Cyclophosphamide 6fludarabine phosphate 4aldesleukin 3Radiotherapy 3Gemcitabine 3Drug Therapy 3Docetaxel 3Cetuximab 3temsirolimus 2sargramostim 2motexafin gadolinium 2liposomal doxorubicin 2fludarabine 2entinostat 2durvalumab 2belinostat 2atezolizumab 2Sirolimus 2Paclitaxel 2Methods 2Metformin 2Irinotecan 2Interferon-alpha 2Bortezomib 23-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 2valspodar 1tremelimumab 1tocilizumab 1tanespimycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Alpelisib × Breast × Clear all
NCT02077933 2020-12-08

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

Novartis

Phase 1 Completed
79 enrolled
BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡